Your browser doesn't support javascript.
loading
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum.
Moreno, Estefanía; Chiarlone, Anna; Medrano, Mireia; Puigdellívol, Mar; Bibic, Lucka; Howell, Lesley A; Resel, Eva; Puente, Nagore; Casarejos, María J; Perucho, Juan; Botta, Joaquín; Suelves, Nuria; Ciruela, Francisco; Ginés, Silvia; Galve-Roperh, Ismael; Casadó, Vicent; Grandes, Pedro; Lutz, Beat; Monory, Krisztina; Canela, Enric I; Lluís, Carmen; McCormick, Peter J; Guzmán, Manuel.
Afiliação
  • Moreno E; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Chiarlone A; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain.
  • Medrano M; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Puigdellívol M; Instituto Universitario de Investigación Neuroquímica and Department of Biochemistry and Molecular Biology I, Complutense University, Madrid, Spain.
  • Bibic L; Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Howell LA; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Resel E; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain.
  • Puente N; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK.
  • Casarejos MJ; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK.
  • Perucho J; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK.
  • Botta J; School of Biological and Chemical Sciences, Queen Mary, University of London, London, UK.
  • Suelves N; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Ciruela F; Instituto Universitario de Investigación Neuroquímica and Department of Biochemistry and Molecular Biology I, Complutense University, Madrid, Spain.
  • Ginés S; Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Galve-Roperh I; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
  • Casadó V; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain.
  • Grandes P; Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Lutz B; Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
  • Monory K; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, UK.
  • Canela EI; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Lluís C; Biomedical Science Department, School of Medicine; Institut d'Investigacions Biomèdiques August Pi i Sunyer, and Neuroscience Institute, Barcelona University, Barcelona, Spain.
  • McCormick PJ; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, IDIBELL, and Neuroscience Institute, Barcelona University, Barcelona, Spain.
  • Guzmán M; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
Neuropsychopharmacology ; 43(5): 964-977, 2018 04.
Article em En | MEDLINE | ID: mdl-28102227

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Corpo Estriado / Estrutura Quaternária de Proteína / Receptor CB1 de Canabinoide / Receptor A2A de Adenosina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Corpo Estriado / Estrutura Quaternária de Proteína / Receptor CB1 de Canabinoide / Receptor A2A de Adenosina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article